Does pimobendan benefit all breeds of dog with preclinical dilated cardiomyopathy when compared to no treatment?
(Elective)
Author
Format
Elective
Status
Online Resources - Online Resources
ELECTIVE 2016 NO. 199
1 available
ELECTIVE 2016 NO. 199
1 available
Description
Loading Description...
Copies
| Location | Call Number | Status |
|---|---|---|
| Online Resources - Online Resources | ELECTIVE 2016 NO. 199 | On Shelf |
Citations
APA Citation, 7th Edition (Style Guide)
Snetcher, L. M. Does pimobendan benefit all breeds of dog with preclinical dilated cardiomyopathy when compared to no treatment?
Chicago / Turabian - Author Date Citation, 18th Edition (Style Guide)Snetcher, Lindsay Marie. Does Pimobendan Benefit All Breeds of Dog With Preclinical Dilated Cardiomyopathy When Compared to No Treatment?
Chicago / Turabian - Humanities (Notes and Bibliography) Citation, 18th Edition (Style Guide)Snetcher, Lindsay Marie. Does Pimobendan Benefit All Breeds of Dog With Preclinical Dilated Cardiomyopathy When Compared to No Treatment? .
UCL Harvard Citation (Style Guide)Snetcher, L. M. (n.d.). Does pimobendan benefit all breeds of dog with preclinical dilated cardiomyopathy when compared to no treatment?
MLA Citation, 9th Edition (Style Guide)Snetcher, Lindsay Marie. Does Pimobendan Benefit All Breeds of Dog With Preclinical Dilated Cardiomyopathy When Compared to No Treatment?
Note: Citations contain only title, author, edition, and publisher. Only UCL Harvard citations contain the year published. Citations should be used as a guideline and should be double checked for accuracy. Citation formats are based on standards as of May 2025.
Staff View
Loading Staff View.